Afferent Pharmaceuticals Announces Positive Results in Phase 2b Chronic Cough Trial
September 28, 2015Clinical trial results show AF-219 treatment significantly reduces cough frequency in patients as well as significant efficacy and improved tolerability at lower doses.
More »
Fractyl Announces Positive Results from 39-Patient Study of RevitaTM DMR System
September 28, 2015Results from the single-site, proof-of-concept study using the Revita™ Duodenal Mucosal Resurfacing™ System produces significant changes in blood sugar control in patients with uncontrolled type 2 diabetes
More »
Celator(R) Pharmaceuticals Announces Positive Results from R&D Programs
September 24, 2015R&D efforts have been successful in applying the CombiPlex® technology platform to optimize the efficacy of anticancer drug combinations incorporating molecularly targeted agents. The data will be presented at the NCI-AACR-EORTC International conference.
More »